Rawson NSB. Alignment of health technology assessments and price negotiations for new drugs for rare disorders in Canada: Does it lead to improved patient access?. J Popl Ther Clin Pharmacol [Internet]. 2020 Feb. 13 [cited 2024 Nov. 18];27(1):e48-e64. Available from: https://mail.jptcp.com/index.php/jptcp/article/view/658